Ergebnis der Suchanfrage nach Allergie

Helmholtz Zentrum München

Follow your gut: How farms protect from childhood asthma

Helmholtz Zentrum München

Nasal biomarkers predict severity of pollen-specific allergy symptoms

Nasal biomarkers predict severity of pollen-specific allergy symptoms It is not only people with allergies, but also a subgroup of people without one that suffer in spring and have nasal problems from contact with pollen. A new study shows that biomarkers in the nose can predict ...

Helmholtz Zentrum München

Helmholtz Zentrum München allies with Eli Lilly and Company to discover new targets for pancreatic beta cell regeneration in the treatment of diabetes

Helmholtz Zentrum München

What the wheat genome tells us about wars

Helmholtz Zentrum München

Pluripotency or differentiation - that is the question

Helmholtz Zentrum München

RNA Transport in Neurons - Staufen2 detects its target transcripts in a complex manner

Helmholtz Zentrum München

2

CD30 - from witness to culprit

Technische Universität München

Salt could be a key factor in allergic immune reactions like atopic dermatitis

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22731 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/detail/article/35257/ Pictures: https://mediatum.ub.tum.de/1475815 NEWS RELEASE Salt could be a key factor in allergic immune reactions Atopic dermatitis: elevated ...

Technische Universität München

New approach to sepsis therapy

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/detail/article/35210/ High resulution image: https://mediatum.ub.tum.de/1471894 NEWS RELEASE Protein engineering extends the language of immune cells Evolution of signaling molecules opens door to new sepsis therapy approaches Small infections can be fatal: Millions of ...

Helmholtz Zentrum München

Two-pronged approach - Novel combined therapy tackles excess fatty tissue

A new combined therapy for obesity and diabetes has been shown to suppress the appetite and at the same time increase energy expenditure. Scientists from the Helmholtz Zentrum München and the Technical University of Munich (TUM), partner institutions of the German Center for ...

Technische Universität München

Test predicts outcome of hay fever therapies

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22731 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/detail/article/35000/ NEWS RELEASE Test predicts outcome of hay fever therapies Allergy researchers look into molecular processes in hyposensitization to pollen Allergen-specific immunotherapy can make everyday life ...

Helmholtz Zentrum München

Satiety in 3D

Many overweight people lack the feeling of being full. It was long thought that this was due to the disrupted transport of the satiety hormone leptin to the brain. That is not the case, as a group of scientists from Helmholtz Zentrum München has now shown in the 'International Journal of Obesity'. The work was made possible by a new 3D imaging technique that allows tracking the path ...

Boehringer Ingelheim

U.S. FDA Approves New Anti-HIV Drug Aptivus(R) for Use in Combination Therapy

Ridgefield, Connecticut (ots/PRNewswire) - - The Following Press Release Was Issued By Our U.S. Affiliate Boehringer Ingelheim Pharmaceuticals, Inc. in The United States on June 23, 2005 Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval of Aptivus(R) (tipranavir) ...